
Keywords: Gut-Kidney axis; Inflammation; Kidney injury; Short-chain fatty acids; AKI; acute kidney injury; βarrs; β-arrestins; cAMP; cyclic adenosine monophosphate; CKD; chronic kidney disease; CIN; contrast-induced nephropathy; ESRD; end-stage renal disease; E